Mission: We study the structural mechanisms of viral infection and other diseases of global health concern, and translate our discoveries into therapeutic strategies.
Scope: We work on viral proteins, not live viruses.
Fang Li, PhD
- Professor and Endowed Chair, Pharmacology, University of Minnesota
- Director, Center for Emerging Viruses
- Founder and CEO, Nanoli Therapeutics
- Co-Director, Midwest Antiviral Drug Discovery Center
Research Highlights:
- Structural biology of virus entry and antiviral development
- Pandemic research from the Li Lab
- How deadly Marburg virus enters human cells
News Highlights:
- Most-cited all-time papers in two leading virology journals
- Clarivate Highly Cited Researcher (5th consecutive year)
- PhD student Fan Bu receives outstanding research award
- 2026 Fang Li Research Awards recipients announced
- New Nature Communications study: novel Ebola entry inhibitor
Opportunities:
Links: Linkedin | Twitter | YouTube | Personal Website